Drug Shortages, Newly Developed Therapies, and Access
ASH provides the following resources to keep physicians informed of newly approved therapies, safety and prescription matters, and shortages of critical hematologic drugs.
ASH provides the following resources to keep physicians informed of newly approved therapies, safety and prescription matters, and shortages of critical hematologic drugs.
Information about hematologic risk evaluation and mitigation strategies(REMs)
Resources to help clinicians and patients access high-cost hematologic drugs
Information and resources regarding shortages of drugs used to treat patients with hematologic diseases
Information about newly approved therapies and other important actions (e.g., updated safety information, new prescribing information) for patients provided in collaboration with the Food and Drug Administration (FDA)
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission